{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T10:40:11Z","timestamp":1741171211594,"version":"3.38.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,3]],"date-time":"2011-05-03T00:00:00Z","timestamp":1304380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s00404-011-1914-x","type":"journal-article","created":{"date-parts":[[2011,5,2]],"date-time":"2011-05-02T07:16:12Z","timestamp":1304320572000},"page":"207-214","source":"Crossref","is-referenced-by-count":2,"title":["Lymphadenectomy as a prognostic marker in uterine non-endometrioid carcinoma"],"prefix":"10.1007","volume":"285","author":[{"given":"Ioannis","family":"Mylonas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Schindlbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,3]]},"reference":[{"key":"1914_CR1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","volume":"59","author":"A Jemal","year":"2009","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225\u2013249. doi: 10.3322\/caac.20006","journal-title":"CA Cancer J Clin"},{"key":"1914_CR2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","volume":"366","author":"F Amant","year":"2005","unstructured":"Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I (2005) Endometrial cancer. Lancet 366:491\u2013505","journal-title":"Lancet"},{"key":"1914_CR3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1634\/theoncologist.8-6-541","volume":"8","author":"LA Gloeckler Ries","year":"2003","unstructured":"Gloeckler Ries LA, Reichman ME, Lewis DR, Hankey BF, Edwards BK (2003) Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist 8:541\u2013552","journal-title":"Oncologist"},{"key":"1914_CR4","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","volume":"355","author":"CL Creutzberg","year":"2000","unstructured":"Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Warlam-Rodenhuis CC, De Winter KA, Lutgens LC, van den Bergh AC, van de Steen-Banasik E, Beerman H, van Lent M (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 355:1404\u20131411. doi: S0140673600021395","journal-title":"Lancet"},{"key":"1914_CR5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00404-006-0138-y","volume":"274","author":"A Papanikolaou","year":"2006","unstructured":"Papanikolaou A, Kalogiannidis I, Goutzioulis M, Misailidou D, Makedos A, Vergote I, Makedos G (2006) Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer. Arch Gynecol Obstet 274:91\u201396. doi: 10.1007\/s00404-006-0138-y","journal-title":"Arch Gynecol Obstet"},{"key":"1914_CR6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.humpath.2004.02.007","volume":"35","author":"J Prat","year":"2004","unstructured":"Prat J (2004) Prognostic parameters of endometrial carcinoma. Hum Pathol 35:649\u2013662","journal-title":"Hum Pathol"},{"key":"1914_CR7","first-page":"237","volume":"10","author":"L Deligdisch","year":"1987","unstructured":"Deligdisch L, Holinka CF (1987) Endometrial carcinoma: two diseases? Cancer Detect Prev 10:237\u2013246","journal-title":"Cancer Detect Prev"},{"key":"1914_CR8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","volume":"15","author":"JV Bokhman","year":"1983","unstructured":"Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15:10\u201317","journal-title":"Gynecol Oncol"},{"key":"1914_CR9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00428-003-0947-3","volume":"444","author":"SF Lax","year":"2004","unstructured":"Lax SF (2004) Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Arch 444:213\u2013223","journal-title":"Virchows Arch"},{"key":"1914_CR10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1525-1438.1999.99038.x","volume":"9","author":"B Jereczek-Fossa","year":"1999","unstructured":"Jereczek-Fossa B, Badzio A, Jassem J (1999) Surgery followed by radiotherapy in endometrial cancer: analysis of survival and patterns of failure. Int J Gynecol Cancer 9:285\u2013294","journal-title":"Int J Gynecol Cancer"},{"key":"1914_CR11","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1525-1438.2006.00576.x","volume":"16","author":"D Faratian","year":"2006","unstructured":"Faratian D, Stillie A, Busby-Earle RM, Cowie VJ, Monaghan H (2006) A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome. Int J Gynecol Cancer 16:972\u2013978","journal-title":"Int J Gynecol Cancer"},{"key":"1914_CR12","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s007610050373","volume":"5","author":"G Dallenbach-Hellweg","year":"1999","unstructured":"Dallenbach-Hellweg G (1999) Histopathologie und Stadieneinteilung des Endometriumkarzinoms inklusive seiner Pr\u00e4kanzerosen. Onkologe 5:388\u2013395","journal-title":"Onkologe"},{"key":"1914_CR13","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","volume":"60","author":"WT Creasman","year":"1987","unstructured":"Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60:2035\u20132041","journal-title":"Cancer"},{"key":"1914_CR14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","volume":"105","author":"S Pecorelli","year":"2009","unstructured":"Pecorelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105:103\u2013104","journal-title":"Int J Gynaecol Obstet"},{"key":"1914_CR15","doi-asserted-by":"crossref","unstructured":"(1989) FIGO stages (announcements). Gynecol Oncol 35:125\u2013127","DOI":"10.1016\/0090-8258(89)90027-9"},{"key":"1914_CR16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ygyno.2010.07.011","volume":"119","author":"PT Soliman","year":"2010","unstructured":"Soliman PT, Frumovitz M, Spannuth W, Greer MJ, Sharma S, Schmeler KM, Ramirez PT, Levenback CF, Ramondetta LM (2010) Lymphadenectomy during endometrial cancer staging: practice patterns among gynecologic oncologists. Gynecol Oncol 119:291\u2013294. doi: 10.1016\/j.ygyno.2010.07.011","journal-title":"Gynecol Oncol"},{"key":"1914_CR17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000069163","volume":"43","author":"J Sehouli","year":"2003","unstructured":"Sehouli J, Camara O, Stengel D, Kohler G, Lichtenegger W (2003) Multi-institutional survey on the value of lymphadenectomy in endometrial carcinoma in Germany. Gynakol Geburtshilfliche Rundsch 43:104\u2013110","journal-title":"Gynakol Geburtshilfliche Rundsch"},{"key":"1914_CR18","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1471-2407-10-224","volume":"10","author":"N Bassarak","year":"2010","unstructured":"Bassarak N, Blankenstein T, Bruning A, Dian D, Bergauer F, Friese K, Mylonas I (2010) Is lymphadenectomy a prognostic marker in endometrioid adenocarcinoma of the human endometrium? BMC Cancer 10:224. doi: 10.1186\/1471-2407-10-224","journal-title":"BMC Cancer"},{"key":"1914_CR19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/gyno.1995.1005","volume":"56","author":"LC Kilgore","year":"1995","unstructured":"Kilgore LC, Partridge EE, Alvarez RD, Austin JM, Shingleton HM, Noojin F 3rd, Conner W (1995) Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 56:29\u201333","journal-title":"Gynecol Oncol"},{"key":"1914_CR20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0002-9378(97)70601-X","volume":"176","author":"JW Orr Jr","year":"1997","unstructured":"Orr JW Jr, Holimon JL, Orr PF (1997) Stage I corpus cancer: is teletherapy necessary? Am J Obstet Gynecol 176:777\u2013788 (discussion 788-779)","journal-title":"Am J Obstet Gynecol"},{"key":"1914_CR21","first-page":"2073","volume":"24","author":"M Ceccaroni","year":"2004","unstructured":"Ceccaroni M, Savelli L, Bovicelli A, Alboni C, Ceccarini M, Farina A, Bovicelli L (2004) Prognostic value of pelvic lymphadenectomy in surgical treatment of apparent stage I endometrial cancer. Anticancer Res 24:2073\u20132078","journal-title":"Anticancer Res"},{"key":"1914_CR22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ygyno.2008.06.010","volume":"111","author":"NR Abu-Rustum","year":"2008","unstructured":"Abu-Rustum NR, Chi DS, Leitao M, Oke EA, Hensley ML, Alektiar KM, Barakat RR (2008) What is the incidence of isolated paraaortic nodal recurrence in grade 1 endometrial carcinoma? Gynecol Oncol 111:46\u201348. doi: 10.1016\/j.ygyno.2008.06.010","journal-title":"Gynecol Oncol"},{"key":"1914_CR23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ygyno.2005.11.032","volume":"102","author":"CV Lutman","year":"2006","unstructured":"Lutman CV, Havrilesky LJ, Cragun JM, Secord AA, Calingaert B, Berchuck A, Clarke-Pearson DL, Soper JT (2006) Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol Oncol 102:92\u201397","journal-title":"Gynecol Oncol"},{"key":"1914_CR24","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1200\/JCO.2005.04.144","volume":"23","author":"JM Cragun","year":"2005","unstructured":"Cragun JM, Havrilesky LJ, Calingaert B, Synan I, Secord AA, Soper JT, Clarke-Pearson DL, Berchuck A (2005) Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol 23:3668\u20133675","journal-title":"J Clin Oncol"},{"key":"1914_CR25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","volume":"373","author":"H Kitchener","year":"2009","unstructured":"Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373:125\u2013136. doi: 10.1016\/S0140-6736(08)61766-3","journal-title":"Lancet"},{"key":"1914_CR26","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","volume":"100","author":"P Benedetti Panici","year":"2008","unstructured":"Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, Angioli R, Tateo S, Mangili G, Katsaros D, Garozzo G, Campagnutta E, Donadello N, Greggi S, Melpignano M, Raspagliesi F, Ragni N, Cormio G, Grassi R, Franchi M, Giannarelli D, Fossati R, Torri V, Amoroso M, Croce C, Mangioni C (2008) Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100:1707\u20131716. doi: 10.1093\/jnci\/djn397","journal-title":"J Natl Cancer Inst"},{"key":"1914_CR27","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.ejca.2010.06.001","volume":"46","author":"I Mylonas","year":"2010","unstructured":"Mylonas I (2010) Inhibin-alpha, -betaA and -betaB subunits in uterine non-endometrioid carcinomas: Prognostic significance and clinical implications. Eur J Cancer 46:2485\u20132493. doi: 10.1016\/j.ejca.2010.06.001","journal-title":"Eur J Cancer"},{"key":"1914_CR28","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.ejca.2007.08.014","volume":"43","author":"N Shabani","year":"2007","unstructured":"Shabani N, Kuhn C, Kunze S, Schulze S, Mayr D, Dian D, Gingelmaier A, Schindlbeck C, Willgeroth F, Sommer H, Jeschke U, Friese K, Mylonas I (2007) Prognostic significance of oestrogen receptor alpha (ERalpha) and beta (ERbeta), progesterone receptor A (PR-A) and B (PR-B) in endometrial carcinomas. Eur J Cancer 43:2434\u20132444. doi: 10.1016\/j.ejca.2007.08.014","journal-title":"Eur J Cancer"},{"key":"1914_CR29","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.ejca.2009.01.008","volume":"45","author":"I Mylonas","year":"2009","unstructured":"Mylonas I, Worbs S, Shabani N, Kuhn C, Kunze S, Schulze S, Dian D, Gingelmaier A, Schindlbeck C, Bruning A, Sommer H, Jeschke U, Friese K (2009) Inhibin-alpha subunit is an independent prognostic parameter in human endometrial carcinomas: analysis of inhibin\/activin-alpha, -betaA and -betaB subunits in 302 cases. Eur J Cancer 45:1304\u20131314. doi: 10.1016\/j.ejca.2009.01.008","journal-title":"Eur J Cancer"},{"key":"1914_CR30","doi-asserted-by":"crossref","unstructured":"K\u00e4ufl SD, Kuhn C, Kunze S, Shabani N, Bruning A, Friese K, Mylonas I (2010) Inhibin\/activin-betaC subunit does not represent a prognostic parameter in human endometrial cancer. Arch Gynecol Obstet. doi: 10.1007\/s00404-010-1614-y","DOI":"10.1007\/s00404-010-1614-y"},{"key":"1914_CR31","doi-asserted-by":"crossref","unstructured":"Mylonas I (2010) Inhibin-betaA subunit immunolabeling as a prognostic factor in endometrioid adenocarcinomas: a matter of evaluation? Arch Gynecol Obstet. doi: 10.1007\/s00404-010-1680-1","DOI":"10.1007\/s00404-010-1680-1"},{"key":"1914_CR32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2307\/2281868","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457\u2013481","journal-title":"J Am Stat Assoc"},{"key":"1914_CR33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR (1972) Regression models and life tables. J R Stat Soc B 34:187\u2013220","journal-title":"J R Stat Soc B"},{"key":"1914_CR34","doi-asserted-by":"crossref","unstructured":"Mylonas I, Matsingou C, K\u00e4ufl SD, Br\u00fcning A (2011) Inhibin\/activin betaE-subunit in uterine endometrioid adenocarcinoma and endometrial cancer cell lines: From immunohistochemistry to clinical testing? Gynecol Oncol. doi: 10.1016\/j.ygyno.2011.03.019","DOI":"10.1016\/j.ygyno.2011.03.019"},{"key":"1914_CR35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","volume":"40","author":"CP Morrow","year":"1991","unstructured":"Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, Graham JE (1991) Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 40:55\u201365","journal-title":"Gynecol Oncol"},{"key":"1914_CR36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ygyno.2006.11.007","volume":"105","author":"RR Barakat","year":"2007","unstructured":"Barakat RR, Lev G, Hummer AJ, Sonoda Y, Chi DS, Alektiar KM, Abu-Rustum NR (2007) Twelve-year experience in the management of endometrial cancer: a change in surgical and postoperative radiation approaches. Gynecol Oncol 105:150\u2013156. doi: 10.1016\/j.ygyno.2006.11.007","journal-title":"Gynecol Oncol"},{"key":"1914_CR37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1525-1438.2007.01020.x","volume":"18","author":"DC Smith","year":"2008","unstructured":"Smith DC, Macdonald OK, Lee CM, Gaffney DK (2008) Survival impact of lymph node dissection in endometrial adenocarcinoma: a surveillance, epidemiology, and end results analysis. Int J Gynecol Cancer 18:255\u2013261. doi: 10.1111\/j.1525-1438.2007.01020.x","journal-title":"Int J Gynecol Cancer"},{"key":"1914_CR38","doi-asserted-by":"crossref","unstructured":"May K, Bryant A, Dickinson HO, Kehoe S, Morrison J (2010) Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev:CD007585. doi: 10.1002\/14651858.CD007585.pub2","DOI":"10.1002\/14651858.CD007585.pub2"},{"key":"1914_CR39","doi-asserted-by":"crossref","first-page":"181963","DOI":"10.1155\/2010\/181963","volume":"2010","author":"R Seracchioli","year":"2010","unstructured":"Seracchioli R, Solfrini S, Mabrouk M, Facchini C, Di Donato N, Manuzzi L, Savelli L, Venturoli S (2010) Controversies in surgical staging of endometrial cancer. Obstet Gynecol Int 2010:181963. doi: 10.1155\/2010\/181963","journal-title":"Obstet Gynecol Int"},{"key":"1914_CR40","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/CCO.0b013e32833b9b75","volume":"22","author":"Y Delpech","year":"2010","unstructured":"Delpech Y, Barranger E (2010) Management of lymph nodes in endometrioid uterine cancer. Curr Opin Oncol 22:487\u2013491. doi: 10.1097\/CCO.0b013e32833b9b75","journal-title":"Curr Opin Oncol"},{"key":"1914_CR41","doi-asserted-by":"crossref","unstructured":"Vorgias G, Fotiou S (2010) The role of lymphadenectomy in uterine carcinosarcomas (malignant mixed mullerian tumours): a critical literature review. Arch Gynecol Obstet doi: 10.1007\/s00404-010-1649-0","DOI":"10.1007\/s00404-010-1649-0"},{"key":"1914_CR42","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/gyno.2000.6067","volume":"80","author":"H Yabushita","year":"2001","unstructured":"Yabushita H, Shimazu M, Yamada H, Sawaguchi K, Noguchi M, Nakanishi M, Kawai M (2001) Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer. Gynecol Oncol 80:139\u2013144","journal-title":"Gynecol Oncol"},{"key":"1914_CR43","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ygyno.2003.08.026","volume":"91","author":"J Gonzalez Bosquet","year":"2003","unstructured":"Gonzalez Bosquet J, Keeney GL, Mariani A, Webb MJ, Cliby WA (2003) Cytokeratin staining of resected lymph nodes may improve the sensitivity of surgical staging for endometrial cancer. Gynecol Oncol 91:518\u2013525","journal-title":"Gynecol Oncol"},{"key":"1914_CR44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00404-008-0893-z","volume":"280","author":"NC Sayin","year":"2009","unstructured":"Sayin NC, Varol FG, Yuce MA, Kaplan P, Ahmet N, Sut N, Gucer F (2009) Do routine preoperative imaging techniques facilitate the operation in endometrial cancer? Arch Gynecol Obstet 280:211\u2013215. doi: 10.1007\/s00404-008-0893-z","journal-title":"Arch Gynecol Obstet"},{"key":"1914_CR45","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1080\/00016340802503054","volume":"87","author":"SJ Chang","year":"2008","unstructured":"Chang SJ, Kim WY, Yoon JH, Yoo SC, Chang KH, Ryu HS (2008) Para-aortic lymphadenectomy improves survival in patients with intermediate to high-risk endometrial carcinoma. Acta Obstet Gynecol Scand 87:1361\u20131369. doi: 10.1080\/00016340802503054","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1914_CR46","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(09)62002-X","volume":"375","author":"Y Todo","year":"2010","unstructured":"Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N (2010) Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 375:1165\u20131172. doi: 10.1016\/S0140-6736(09)62002-X","journal-title":"Lancet"},{"key":"1914_CR47","doi-asserted-by":"crossref","unstructured":"Yoon JH, Yoo SC, Kim WY, Chang SJ, Chang KH, Ryu HS (2010) Para-aortic Lymphadenectomy in the Management of Preoperative Grade 1 Endometrial Cancer Confined to the Uterine Corpus. Ann Surg Oncol. doi: 10.1245\/s10434-010-1199-5","DOI":"10.1245\/s10434-010-1199-5"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-011-1914-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-011-1914-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-011-1914-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T09:57:25Z","timestamp":1741168645000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-011-1914-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,3]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["1914"],"URL":"https:\/\/doi.org\/10.1007\/s00404-011-1914-x","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"type":"print","value":"0932-0067"},{"type":"electronic","value":"1432-0711"}],"subject":[],"published":{"date-parts":[[2011,5,3]]}}}